Skip to content

Investigating the effect of sacral ESP block on postoperative pain management in perineal surgeries

Investigating the effect of sacral ESP block on postoperative pain management in perineal surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250531066000N1
Enrollment
60
Registered
2025-06-20
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoidectomy. First degree hemorrhoids

Interventions

Intervention 1: Intervention group: Intervention group: Bilateral SESPB block + standard care. Intervention 2: control group: Receive general anesthesia with LMARoutine pain management with IV paracet

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who are candidates for perineal surgery (such as hemorrhoidectomy, fistula surgery, or anal fissure) both sexes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Immediately upon awakening (T0), 2 hours postoperatively (T2), 6 hours postoperatively (T6), 12 hours postoperatively (T12), 24 hours postoperatively (T24). Method of measurement: Numeric Rating Scale 0-10.

Secondary

MeasureTime frame
Analgesic Consumption. Timepoint: Exact recording of type, dose, and timing of all analgesics (morphine, paracetamol, ketorolac) within 24h. Method of measurement: Total morphine milligram equivalents (MME) calculated per WHO guidelines.;Hospital Stay Duration. Timepoint: Exact discharge time (in hours) recorded from surgery end time. Method of measurement: Compared with the hospital’s standard average.;Patient Satisfaction. Timepoint: end time. Method of measurement: Assessed via 5-point Likert scale (1: Very dissatisfied, 5: Very satisfied) at discharge.;Adverse Effects. Timepoint: Continuous monitoring for up to 24 hours after the operation. Method of measurement: Documented per CTCAE v5.0 criteria (nausea, vomiting, hypotension, motor weakness).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSawalan Aidenlou

Iran University of Medical Sciences

Aidenlousawalan@ gmail+98 21 86701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026